DLD1 cells were seeded in 6-well plates (BRCA2 WT cells 1 x105 cells; BRCA2-/- cells 2 x105 )
Next day either left untreated or treated with hmdU (1 µM) and olaparib (100 nM) for 48 hrs.
Cells were then labeled with 20 µM CldU for 20 mins, washed once with medium followed by a second labelling with 150 µM IdU for 20 mins.
Cells were pre-extracted with cold CSK buffer for 5 mins on ice and scraped in PBS and transferred to an Eppendorf tube on ice.
Two µL of the cell suspension was placed on the top of a glass slide (Superfrost, 90o edges) followed by addition of 12 µL of lysis buffer (0.5% sodium dodecyl sulfate (SDS), 200 mM Tris-HCl pH 7.4, 50 mM ethylenediaminetetraacetic acid (EDTA)) and slowly mixed.
The slides were left for 2 mins and DNA was spread by tilting them at a 10-15o angle to allow it to run slowly downwards to the end of the slide and left for 5 mins to dry.
The slides were fixed in a methanol:acetic acid solution (3:1) for 15 mins at room temperature (RT) and left to air dry.
The DNA fibres were denatured by incubating the slides in 2.5 M HCl solution for 60 mins at RT.
Slides were washed twice in PBS and blocked in PBS supplemented with 2% bovine serum albumin (BSA) for 30 mins at RT.
Slides were stained with rat anti-BrdU (Serotec, BU1/75, OBT0030CX; 1:1200 dilution) and mouse anti-BrdU (BD, B44; 1:500) in PBS/2% BSA overnight at 4oC.
Slides were washed twice in PBS and stained with anti-rat Alexa 594 and anti-mouse Alexa 488 (1:500) in PBS/2% BSA for 1 hour at RT.
Slides were washed twice in PBS followed by one wash in ddH2O and left to air dry in the dark.
Slides were mounted with Prolong Gold and images were acquired on a AxioImagerM2 microscope (Zeiss) equipped with Plan-Apochromat 40x/1.4 Oil objective (Zeiss) using Volocity software.
Fugger, K., Bajrami, I., Santos, M. S. D., Young, S. J., Kunzelmann, S., Kelly, G., Hewitt, G., Patel, H., Goldstone, R., Carell, T., Boulton, S. J., MacRae, J., Taylor, I. A. and West, S. C.(2021). Targeting the nucleotide salvage factor DNPH1 sensitizes BRCA-deficient cells to PARP inhibitors . Science 372(6538). DOI: 10.1126/science.abb4542
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this
article to respond.
0/150
Tips for asking effective questions
+ Description
Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.
Spinning
Post a Question
0 Q&A
Spinning
This protocol preprint was submitted via the "Request
a Protocol" track.